君实生物公告,2025年4月25日召开的第四届董事会第八次会议审议通过了《关于聘任证券事务代表的议案》,同意聘任王雨舟女士为公司证券事务代表,任期自本次董事会审议通过之日起至第四届董事会届满之日止。王雨舟女士具备上海证券交易所科创板董事会秘书资格证书,曾在沣石(上海)投资管理有限公司担任投资经理,并于2021年5月加入君实生物,历任证券副经理、证券部经理。截至公告披露日,王雨舟女士直接持有公司3,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.